Generics 12

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Fluticasone furoate manufacturers

12 products found

Filters

fluticasone furoate + vilanterol

Inhalation powder 92 mcg + 22 mcg, 184 mcg + 22 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref:Relvar® Ellipta®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 12 days

fluticasone furoate + umeclidinium bromide + vilanterol

Inhalation powder 92 mcg + 55 mcg + 22 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Trelegy Ellipta®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 12 days

fluticasone furoate

Nasal spray 27.5 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark , Finland , Iceland , Norway , Sweden
Manufacturer #350
This EU pharmaceutical company specializes in out-licensing and development services for clients globally. They offer a range of dosage forms including solids, injectables, nasals, creams, and oral liquids across multiple therapy areas. While specific therapy areas aren't listed, they highlight their commitment to quality and accountability, mentioning GMP certifications and product patents. The company operates within the EU and serves markets worldwide through its affiliation with the A.forall Group.

Manufacturer usually replies in 6 days

Want to see all 12 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Fluticasone Furoate Manufacturer

Fluticasone Furoate is sold under the brand name “Arnuity”, “Ellipta”, “Avamys”, and “Breo Ellipta”. It belongs to a class of drugs known as Intranasal Corticosteroids. It is a prescription and over-the-counter pharmaceutical medicine that treats allergic rhinitis and nasal polyps. Use this pharmaceutical medicine alone or in combination with other drugs. Its safety and efficacy in children younger than 2 years of age are not yet known. The only way to administer this nasal spray is through the nasal passages. Before using the nasal spray for the first time, shake the contents well and spray 6 sprays into the nostril, away from the face. The nasal spray should be re-primed if it hasn't been used in 30 days or if the cap has been off for 5 days or more. It should be thoroughly shaken before each use. The side effects related to this drug are severe or ongoing nosebleeds, noisy breathing, runny nose, crusting around your nostrils, redness, sores, or white patches in your mouth or throat, fever, chills, and body aches. Humans have not yet been subjected to any well-controlled research studies regarding the use of this drug during pregnancy. If the potential benefits to the mother outweigh the potential risks to the unborn child, this medication can be used. As of now, it is unknown if this drug crosses into human milk during administration. A decision should be made about whether to stop nursing or stop using this medication as many medications can cross into human milk. There is the potential for serious adverse reactions in nursing infants when using this medication.

How does Fluticasone Furoate work?

Various cell types and inflammation mediators are affected by Fluticasone Furoate through an unknown mechanism. Fluticasone Furoate activates glucocorticoid receptors, inhibits nuclear factor-kappa b, and inhibits lung eosinophilia.

The cost of Fluticasone Furoate

On average, you'll pay around $16 for a 16-gram supply of fluticasone nasal spray (50mcg).

Sourcing the Fluticasone Furoate Manufacturer and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The list of Fluticasone Furoate offerings can be narrowed down with the use of filters and easily weighed against other manufacturers and suppliers according to medication prices and commercial terms. The advanced filters on our website also help you filter out the countries this substance is manufactured and marketed by. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Fluticasone Furoate Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Fluticasone Furoate is already registered in.

Establishing commercial ties

Drug dealers, wholesalers, and buyers can use Pipelinepharma as a secure and safe B2B platform for drug deals. A pharmaceutical license allows drug sellers to register and advertise as many drugs as they desire. And the sellers can work with drug distributors and provide tertiary services directly to the customers themselves.

Quality Assurance

As part of their quality control operations, Pipeline pharma verifies the seller's information at the time of registration. When it comes to marketing pharmaceuticals, they make sure that they are free of flaws and that the duration of use has been verified.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation